4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001179110-11-004052
Sr. VP, Drug Development sold 18,270 shares at $5.23 ($95,552)
- Sr. VP, Drug Development acquired 6,844 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Koya Keizo Sr. VP, Drug Development | 2011-03-01 | Sale | −18,270 | $5.23 | $95,552 | 32,999 | D |
| Koya Keizo Sr. VP, Drug Development | 2011-03-01 | Grant or award | +6,844 | 39,843 | D | ||
| Derivatives | |||||||
| Koya Keizo Sr. VP, Drug Development | 2011-03-01 | Grant or award · Employee Stock Option (Right to Buy) | +58,200 | 58,200 | D | ||
| Open-market sales · 18,270 sh · avg $5.23 · $95,552 | |||||||
Loading xslF345X03/edgar.xml…